Cargando…
Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank
BACKGROUND: Many different combinations of available data have been used to identify gout cases in large genetic studies. The aim of this study was to determine the performance of case definitions of gout using the limited items available in multipurpose cohorts for population-based genetic studies....
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551011/ https://www.ncbi.nlm.nih.gov/pubmed/28793914 http://dx.doi.org/10.1186/s13075-017-1390-1 |
_version_ | 1783256228612276224 |
---|---|
author | Cadzow, Murray Merriman, Tony R. Dalbeth, Nicola |
author_facet | Cadzow, Murray Merriman, Tony R. Dalbeth, Nicola |
author_sort | Cadzow, Murray |
collection | PubMed |
description | BACKGROUND: Many different combinations of available data have been used to identify gout cases in large genetic studies. The aim of this study was to determine the performance of case definitions of gout using the limited items available in multipurpose cohorts for population-based genetic studies. METHODS: This research was conducted using the UK Biobank Resource. Data, including genome-wide genotypes, were available for 105,421 European participants aged 40–69 years without kidney disease. Gout definitions and combinations of these definitions were identified from previous epidemiological studies. These definitions were tested for association with 30 urate-associated single-nucleotide polymorphisms (SNPs) by logistic regression, adjusted for age, sex, waist circumference, and ratio of waist circumference to height. Heritability estimates under an additive model were generated using GCTA version 1.26.0 and PLINK version 1.90b3.32 by partitioning the genome. RESULTS: There were 2066 (1.96%) cases defined by self-report of gout, 1652 (1.57%) defined by urate-lowering therapy (ULT) use, 382 (0.36%) defined by hospital diagnosis, 1861 (1.76%) defined by hospital diagnosis or gout-specific medications and 2295 (2.18%) defined by self-report of gout or ULT use. Association with gout at experiment-wide significance (P < 0.0017) was observed for 13 SNPs with gout using the self-report of gout or ULT use definition, 12 SNPs using the self-report of gout definition, 11 SNPs using the hospital diagnosis or gout-specific medication definition, 10 SNPs using ULT use definition and 3 SNPs using hospital diagnosis definition. Heritability estimates ranged from 0.282 to 0.308 for all definitions except hospital diagnosis (0.236). CONCLUSIONS: Of the limited items available in multipurpose cohorts, the case definition of self-report of gout or ULT use has high sensitivity and precision for detecting association in genetic epidemiological studies of gout. |
format | Online Article Text |
id | pubmed-5551011 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-55510112017-08-14 Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank Cadzow, Murray Merriman, Tony R. Dalbeth, Nicola Arthritis Res Ther Research Article BACKGROUND: Many different combinations of available data have been used to identify gout cases in large genetic studies. The aim of this study was to determine the performance of case definitions of gout using the limited items available in multipurpose cohorts for population-based genetic studies. METHODS: This research was conducted using the UK Biobank Resource. Data, including genome-wide genotypes, were available for 105,421 European participants aged 40–69 years without kidney disease. Gout definitions and combinations of these definitions were identified from previous epidemiological studies. These definitions were tested for association with 30 urate-associated single-nucleotide polymorphisms (SNPs) by logistic regression, adjusted for age, sex, waist circumference, and ratio of waist circumference to height. Heritability estimates under an additive model were generated using GCTA version 1.26.0 and PLINK version 1.90b3.32 by partitioning the genome. RESULTS: There were 2066 (1.96%) cases defined by self-report of gout, 1652 (1.57%) defined by urate-lowering therapy (ULT) use, 382 (0.36%) defined by hospital diagnosis, 1861 (1.76%) defined by hospital diagnosis or gout-specific medications and 2295 (2.18%) defined by self-report of gout or ULT use. Association with gout at experiment-wide significance (P < 0.0017) was observed for 13 SNPs with gout using the self-report of gout or ULT use definition, 12 SNPs using the self-report of gout definition, 11 SNPs using the hospital diagnosis or gout-specific medication definition, 10 SNPs using ULT use definition and 3 SNPs using hospital diagnosis definition. Heritability estimates ranged from 0.282 to 0.308 for all definitions except hospital diagnosis (0.236). CONCLUSIONS: Of the limited items available in multipurpose cohorts, the case definition of self-report of gout or ULT use has high sensitivity and precision for detecting association in genetic epidemiological studies of gout. BioMed Central 2017-08-09 2017 /pmc/articles/PMC5551011/ /pubmed/28793914 http://dx.doi.org/10.1186/s13075-017-1390-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Cadzow, Murray Merriman, Tony R. Dalbeth, Nicola Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank |
title | Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank |
title_full | Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank |
title_fullStr | Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank |
title_full_unstemmed | Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank |
title_short | Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank |
title_sort | performance of gout definitions for genetic epidemiological studies: analysis of uk biobank |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551011/ https://www.ncbi.nlm.nih.gov/pubmed/28793914 http://dx.doi.org/10.1186/s13075-017-1390-1 |
work_keys_str_mv | AT cadzowmurray performanceofgoutdefinitionsforgeneticepidemiologicalstudiesanalysisofukbiobank AT merrimantonyr performanceofgoutdefinitionsforgeneticepidemiologicalstudiesanalysisofukbiobank AT dalbethnicola performanceofgoutdefinitionsforgeneticepidemiologicalstudiesanalysisofukbiobank |